BE902308A - PROCESS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS. - Google Patents

PROCESS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS.

Info

Publication number
BE902308A
BE902308A BE0/214929A BE214929A BE902308A BE 902308 A BE902308 A BE 902308A BE 0/214929 A BE0/214929 A BE 0/214929A BE 214929 A BE214929 A BE 214929A BE 902308 A BE902308 A BE 902308A
Authority
BE
Belgium
Prior art keywords
bone
osteoporosis
prevention
treatment
during
Prior art date
Application number
BE0/214929A
Other languages
French (fr)
Inventor
L Flora
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BE902308A publication Critical patent/BE902308A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procédé pour traiter ou prévenir l'ostéoporose par lequel les cellules osseuses sont amenées en synchronisme au cours d'une période activatrice ds cellules osseuses, la résorption osseuse qui suit normalement l'activation est inhibée en utilisant un polyphosphonate et la formation osseuse est admise à se produire au cours de la période de repos pendant laquelle des suppléments de nutrition peuvent s'administrer au patient.Method for treating or preventing osteoporosis by which the bone cells are brought into synchronism during an activating period of the bone cells, the bone resorption which normally follows the activation is inhibited using a polyphosphonate and the bone formation is admitted to occur during the rest period during which nutritional supplements may be administered to the patient.

BE0/214929A 1984-04-30 1985-04-29 PROCESS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS. BE902308A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60554184A 1984-04-30 1984-04-30
US68454284A 1984-12-21 1984-12-21

Publications (1)

Publication Number Publication Date
BE902308A true BE902308A (en) 1985-10-29

Family

ID=27084978

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214929A BE902308A (en) 1984-04-30 1985-04-29 PROCESS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS.

Country Status (5)

Country Link
AU (1) AU569391B2 (en)
BE (1) BE902308A (en)
DE (1) DE3514584A1 (en)
IT (1) IT1188160B (en)
PH (1) PH21642A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381296B1 (en) * 1984-04-30 1994-11-30 THE PROCTER & GAMBLE COMPANY Kit for use in the treatment of osteoporosis
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis
DD285240A7 (en) * 1988-09-27 1990-12-12 Technisches Glas Veb K METHOD FOR PRODUCING AN OSTEOINDUCTIVE BONE REPLACEMENT MATERIAL
AU8083694A (en) * 1993-10-19 1995-05-08 Merck & Co., Inc. Combination of bisphosphonates and growth hormone secretagogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
DE3243358A1 (en) * 1982-11-24 1984-05-24 Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch SYNTHETIC HUMANES (1-38) PARATHORMONE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND THE USE FOR TREATING THE OSTEOPOROSIS
EP0381296B1 (en) * 1984-04-30 1994-11-30 THE PROCTER & GAMBLE COMPANY Kit for use in the treatment of osteoporosis
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis

Also Published As

Publication number Publication date
PH21642A (en) 1988-01-13
IT1188160B (en) 1988-01-07
AU4148485A (en) 1985-11-07
IT8520448A1 (en) 1986-10-23
AU569391B2 (en) 1988-01-28
DE3514584A1 (en) 1985-10-31
IT8520448A0 (en) 1985-04-23

Similar Documents

Publication Publication Date Title
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
ATE258065T1 (en) TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTOANTIGENS
AU6760987A (en) Method of treating alzheimer's disease
EP0553291A4 (en) Treatment of autoimmune diseases by oral administration of autoantigens
BE901915A (en) PROCESS FOR THE TREATMENT OR PREVENTION OF DISEASES CAUSED BY ACETHER OF THE PLATELET ACTIVATION FACTOR.
HU9302407D0 (en) Preparatives for treating osteoporosis
ZA876483B (en) Therapeutic composition and method
PL253202A1 (en) Method of obtaining 2-amino-3-etoxycarbonylamino-6-/p-fluorobenzylamino/-pyridine gluconate
BE902307A (en) PROCESS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS.
ATE135914T1 (en) AICA RIBOSIDE FOR THE PROPHYLACTIC TREATMENT OF DISEASES INVOLVING REDUCED BLOOD CIRCULATION.
KR970009582B1 (en) Method for the treatment of oste oporosis and related disorders
BE900012A (en) NEW PEPTIDE.
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
CZ28395A3 (en) Therapeutic composition containing whey protein concentrate
HU9204171D0 (en) Method for producing aralkyl esters of 4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-anthracene-carboxylic acid as well as medical preparatives containing them
HU890380D0 (en) Process for producing (mercapto-acyl)-amino acid derivatives and pharmaceutical preparatives containing these compounds
HUT46216A (en) Process for production of improved antiimflammation composition and method of treatment
UA19335A (en) Method for preparation of remedy for the treatment of the psoriasis type deseasis
UA19674A (en) Composition for treating contact lenses
EP0330756A3 (en) Thienotricyclics for the treatment of bronchial diseases
ATE108664T1 (en) METHODS TO PREVENT GVHD.
LTIP1535A (en) Method for treatment of skins and hides
AU7491487A (en) Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.
IL67802A0 (en) Process for controlling patterns of chemical stimuli administration to biological tissue
JO1493B1 (en) Pharmaceutical compositions for the treatment of high blood pressure

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20040430